← Eichor
Condition: Delusional Disorder Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Delusional Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
Phase 2 · 3 location(s) · MapLight Therapeutics · NCT07459660Tau Biomarkers in Late-onset Psychosis (LOP)
Phase N/A · 1 location(s) · Jeremy Koppel · NCT06336382Tau Networks in Psychotic Alzheimer's Disease
Phase N/A · 1 location(s) · Northwell Health · NCT05847192A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Phase 2 · 40 location(s) · MapLight Therapeutics · NCT06887192Comparing Antipsychotic Medications in LBD Over Time
Phase 4 · 2 location(s) · The University of Texas Health Science Center at San Antonio · NCT05590637Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Phase N/A · 6 location(s) · Beth Israel Deaconess Medical Center · NCT06740383Immune Mechanisms of Antipsychotic Treatment Response
Phase N/A · 1 location(s) · King's College London · NCT06687694FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis
NA · 8 location(s) · Stephanie Mehl · NCT07645443Asylumseekers Experiencing Paranoid Delusions: A Virtual Reality Study
Phase N/A · 1 location(s) · University Medical Center Groningen · NCT06692530Feeling Safe Study
NA · 1 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT07234708The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric Care
NA · 1 location(s) · University of Jyvaskyla · NCT06005766Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy
NA · 1 location(s) · Vanderbilt University Medical Center · NCT06835556ACP-204 in Adults With Alzheimer's Disease Psychosis
Phase 2/Phase 3 · 148 location(s) · ACADIA Pharmaceuticals Inc. · NCT06159673
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.